Herpes zoster and multiple sclerosis disease modifying therapies

Key Points

• To explore the relationship between herpes zoster and disease modifying therapies used in multiple sclerosis.
• Review of existing literature on herpes zoster incidence in multiple sclerosis patients
• Analysis of immunosuppressive effects of various therapies
• Comparison of herpes zoster rates between different treatment groups.
• Increased herpes zoster incidence observed in patients receiving certain immunomodulatory therapies
• Higher risks associated with specific disease modifying therapies like natalizumab and fingolimod
• Support for vaccination and preventive measures in high-risk therapy groups.